Devin Medical Debuts at IGILUC 2026, Chinese Minimally Invasive Interventional Techniques Gain Spotlight in Egypt
Release time:
2026-08-06
Hosted in Cairo, Egypt from January 22 to 23, 2026, IGILUC 2026 drew worldwide attention from the global interventional medicine community. Nanjing Devin Medical Technology Co., Ltd. made a high-profile appearance with its cutting-edge tumor ablation devices and innovative therapeutic solutions. Leveraging domestically developed proprietary technologies, the firm engaged in international academic exchanges and contributed Chinese expertise to safeguard the health of cancer patients worldwide.
During specialized workshops at the conference, Devin Medical’s team held in-depth discussions with top interventional specialists from Egypt and across the globe concerning innovative applications of microwave ablation for liver tumors, thyroid nodules, pulmonary lesions and other clinical scenarios. Our self-developed MRI-compatible microwave ablation system won wide acclaim from attending experts for its intelligent precise targeted positioning and efficient tumor ablation performance.
Through live clinical demonstrations and long-term curative effect data presentations, Devin’s treatment protocols minimize damage to healthy tissue while greatly improving patients’ quality of life, fully demonstrating the robust competitiveness of China’s interventional medical devices.
This exhibition in Egypt not only serves as international recognition of Devin Medical’s technological strength but also marks a key milestone in the company’s global expansion strategy. A pioneering innovator within China’s interventional medicine industry, the company adheres to its mission of enabling global patients to access precise diagnosis and treatment, and actively promotes the global adoption of ablation technologies.
Given the continuous rise in global cancer incidence, minimally invasive and precise interventional therapy has become a core developmental trend in modern medicine. Building on its participation in IGILUC 2026, Devin Medical will accelerate clinical promotion and market deployment of its products across the Middle East, Africa, Europe and other regions.
We firmly believe that technological innovation paired with deepened international cooperation will help us fulfill our vision: Ablate one tumor, save one life. Moving forward, Devin Medical will partner with global counterparts to fuel progress in global oncology treatment with state-of-the-art technologies, premium products and comprehensive services, carving a brilliant chapter for Chinese medical technology in the global healthcare landscape.


Related news